Commission on Excellence and Innovation in Health

Cancer Statewide Clinical Network

The Cancer SCN brings together health professionals and consumers to provide strategic guidance and advice relating to cancer care and work on projects to improve health outcomes for all South Australians affected by cancer.

Current projects

South Australian Cancer Plan

Can­cer affects an esti­mat­ed one-third of the Aus­tralian pop­u­la­tion dur­ing their life­time, includ­ing fam­i­lies, car­ers and sup­port­ers of peo­ple diag­nosed with can­cer. In 2019 over 11,000 South Aus­tralians were diag­nosed with can­cer (Source: Can­cer Coun­cil SA) and across Aus­tralia it is a major cause of ill­ness respon­si­ble for 18% of the bur­den of ill health (Source: Aus­tralian Insti­tute of Health and Welfare).

The SA Gov­ern­ment has com­mit­ted to devel­op­ing and imple­ment­ing a new five-year SA Can­cer Plan.

The Plan aims to improve can­cer out­comes for all South Aus­tralians through a coor­di­nat­ed, strate­gic direc­tion that iden­ti­fies future oppor­tu­ni­ties to reduce the inci­dence of can­cer in the pop­u­la­tion, improve the can­cer expe­ri­ence for peo­ple diag­nosed with can­cer and their families/​carers, and to improve qual­i­ty of life and improve long-term post-diag­no­sis survival.

The Plan will pro­vide clear guid­ance to SA Health and part­ners on the future direc­tions and pri­or­i­ties for can­cer care, and will be used to inform future ser­vice plan­ning, mod­els of care and sys­tem wide decisions.

The Depart­ment for Health and Well­be­ing is lead­ing devel­op­ment of the Plan in part­ner­ship with the Can­cer Statewide Clin­i­cal Net­work (SCCN). Dr Michael Osborn, Clin­i­cal Lead of the Can­cer SCN, along with sev­er­al mem­bers of the Can­cer SCN Steer­ing Com­mit­tee are mem­bers of the SA Can­cer Plan Project Board. 

The Plan is being informed by com­mu­ni­ty expe­ri­ences with can­cer pre­ven­tion and care in SA. Peo­ple with expe­ri­ence of can­cer and their fam­i­lies and car­ers, health­care prac­ti­tion­ers across the pub­lic and pri­vate sec­tor, researchers, edu­ca­tors and the gen­er­al com­mu­ni­ty have con­tributed their expe­ri­ences and ideas, through in per­son and online forums.

For more infor­ma­tion, please vis­it the SA Can­cer Plan web­page on the SA Health website.

Germline Testing

Germline test­ing pro­vides impor­tant infor­ma­tion to guide treat­ment deci­sions in can­cer care. The use of germline test­ing in can­cer care has expand­ed rapid­ly in recent years, part­ly due to the growth in knowl­edge and tech­nol­o­gy around genet­ic test­ing, includ­ing new treat­ment options avail­able based on genet­ic test­ing results and an expan­sion in eli­gi­bil­i­ty cri­te­ria for germline testing.

To sup­port a stream­lined and con­sis­tent path­way for patients access­ing germline test­ing, the Can­cer Statewide Clin­i­cal Net­work (CSCN) iden­ti­fied the need for a co-devel­oped statewide frame­work. The devel­op­ment of the frame­work was guid­ed by a mul­ti-dis­ci­pli­nary work­ing group, includ­ing rep­re­sen­ta­tion from SA Pathol­o­gy, Ade­laide Genet­ics Unit (AGU), Local Health Net­works (LHN) and consumers.

The work­ing group, led by Dr Eryn Dow Clin­i­cal Can­cer Geneti­cist from AGU, under­took con­sul­ta­tion with rel­e­vant stake­hold­ers across all SA LHNs which informed a com­pre­hen­sive review of the cur­rent germline test­ing prac­tice and path­ways across LHNs.

To sup­port the frame­work, main­stream genet­ic packs were devel­oped and endorsed by the Can­cer SCN. These packs are avail­able on the Adult Genet­ics Unit AGU web­site for clin­i­cians across the health sys­tem to sup­port main­stream germline test­ing. The packs include infor­ma­tion sheets, flow­charts, con­sent forms, test­ing cri­te­ria, guides, con­sent forms and par­tial­ly filled pathol­o­gy request forms. Edu­ca­tion to sup­port the frame­work and use of the packs was pro­vid­ed to can­cer focussed mul­ti-dis­ci­pli­nary team (MTD) meet­ing across LHNs.

Eval­u­a­tion of the frame­work is under­way, to mea­sure effec­tive­ness in terms of imple­men­ta­tion, util­i­ty and out­comes. Con­sumer expe­ri­ence and sat­is­fac­tion with the main­stream­ing process will also be captured.

We would like to thank SA Pathol­o­gy for their con­tri­bu­tion toward the project to enable high lev­el high lev­el data over­sight and enable the eval­u­a­tion and mon­i­tor­ing of main­stream­ing germline test­ing rates.

Cancer Navigation

Can­cer nav­i­ga­tion refers to how a patient nav­i­gates can­cer care and is a key ele­ment of coor­di­nat­ed, per­son-cen­tred care and sup­port. Can­cer nav­i­ga­tion works to improve access to care and con­ti­nu­ity of care, par­tic­u­lar­ly among pop­u­la­tions expe­ri­enc­ing unmet needs and dis­par­i­ties in can­cer care. 

The Can­cer Statewide Clin­i­cal Net­work (SCN) rat­ed effi­cient and equi­table can­cer nav­i­ga­tion as the high­est pri­or­i­ty to improve and address in 2023. This was iden­ti­fied through a com­pre­hen­sive work­shop­ping process under­tak­en with the SCCN to iden­ti­fy and pri­ori­tise net­work projects. 

We’re excit­ed to part­ner with the Car­ing Futures Insti­tute (CFI) on the Can­cer Nav­i­ga­tion Project’, to devel­op South Aus­tralian can­cer nav­i­ga­tion frame­work, which imag­ines a future where the high­est stan­dard of health­care is avail­able to all and where peo­ple are tru­ly at the centre. 

The Can­cer Nav­i­ga­tion Project will soon com­mence con­sumer and stake­hold­er (includ­ing can­cer care pro­fes­sion­als, gov­ern­ment, and non-gov­ern­ment organ­i­sa­tions) engage­ment to co-design the frame­work and imple­men­ta­tion plan and con­sid­er appli­ca­tion to the South Aus­tralian Can­cer Plan cur­rent­ly under development. 

The SA Can­cer Plan is envis­aged to set the future direc­tion of can­cer care across SA and helps to iden­ti­fy oppor­tu­ni­ties to cre­ate a coor­di­nat­ed, inte­grat­ed, equi­table, evi­dence-based, per­son­alised care sys­tem across the can­cer con­tin­u­um. Key intend­ed clin­i­cal ben­e­fits include: 

  • Improved time­ly access to and pro­vi­sion of safe and acces­si­ble ser­vices that are inclu­sive of mul­ti­dis­ci­pli­nary teams, as close to home as pos­si­ble for patients. 
  • Improved health sta­tus of the South Aus­tralian pop­u­la­tion whilst devel­op­ing a health sys­tem that facil­i­tates equi­ty of access. 
  • Cre­ation of a respon­sive health sys­tem that meets the needs of the community. 
Chimeric Antigen Receptor T-cell (CAR T-cell) Therapy

The Can­cer Statewide Clin­i­cal Net­work have led col­lab­o­ra­tions with a mul­ti­dis­ci­pli­nary group of clin­i­cians and researchers across all local health net­works to out­line what is need­ed to facil­i­tate the deliv­ery of CAR T‑cells in South Aus­tralia. A project has been ini­ti­at­ed to inves­ti­gate and for­mu­late strate­gies to estab­lish a CAR T‑cell ther­a­py ser­vice in South Australia. 

Chimeric Anti­gen Recep­tor T‑cell (CAR T‑cell) Ther­a­py is an evi­dence-based, inter­na­tion­al­ly recog­nised ther­a­py endorsed by Can­cer Aus­tralia and the Aus­tralian Gov­ern­ment Med­ical Spe­cial­ist Advi­so­ry Com­mit­tee (MSAC) which can improve chance of cure for cer­tain types of leukaemia and lym­phoma. The estab­lish­ment of a South Aus­tralian ser­vice would allow patients to access this care clos­er to home there­by improv­ing their qual­i­ty of life. It would also enhance equi­ty of access for those who may be unable to trav­el inter­state to receive this treatment. 

What is CAR T‑cell ther­a­py? An intro­duc­tion to CAR T‑cell ther­a­py video has been pub­lished by NSW Health Immune Effec­tor Cell Ser­vice which was in part­ner­ship with the NSW Agency for Clin­i­cal Innovation. 

For more infor­ma­tion, vis­it the Agency for Clin­i­cal Infor­ma­tion web­site.

Developing a standardised platform to assist with multidisciplinary team (MDT) meetings.

Can­cer care in Aus­tralia is best pro­vid­ed by a mul­ti­dis­ci­pli­nary team of pro­fes­sion­als. Reg­u­lar mul­ti­dis­ci­pli­nary team (MDT) meet­ings are an inte­gral com­po­nent of pro­vid­ing com­pre­hen­sive care to peo­ple with can­cer. Dur­ing these meet­ings, clin­i­cians review the radi­ol­o­gy and pathol­o­gy results and dis­cuss the most appro­pri­ate treat­ment plan for an indi­vid­ual patient. 

In South Aus­tralia, there are more than 30 MDT meet­ings occur­ring every month inte­grat­ed across the pub­lic and pri­vate sec­tor, how­ev­er cur­rent­ly, there is no state-wide stan­dard­ised approach to doc­u­ment­ing MDTs’ and cap­tur­ing MDT data. We are work­ing toward imple­ment­ing a plat­form that con­nects vital patient infor­ma­tion and results in order to bet­ter sup­port the impor­tant deci­sion mak­ing and planning. 

The Can­cer Statewide Clin­i­cal Net­work has con­tributed to out­lin­ing MDT spec­i­fi­ca­tion require­ments, based on the out­comes of a stake­hold­er engage­ment work­shop which involved clin­i­cal experts and consumers. 

Upcom­ing projects

  • Imple­men­ta­tion of the SA Can­cer Plan — The Can­cer SCN will play a cen­tral role in imple­ment­ing the key com­po­nents of the SA Can­cer Plan. This is due to com­mence late 2023.

Hear from Dr Ganes­san Kichenadasse about the Can­cer Statewide Clin­i­cal Net­work as part of the 2022 CEIH Con­ver­sa­tion Series

Cancer Statewide Clinical Network Steering Committee

Dr Michael Osborn

Haematologist/​Pae­di­atric Oncol­o­gist, WCHN; Ado­les­cent and Young Adult Oncol­o­gist, RAH; and Clin­i­cal Lead Can­cer Statewide Clin­i­cal Network

A/​Prof Amitesh RoyAsso­ciate Pro­fes­sor, Flinders Uni­ver­si­ty School of Med­i­cine; Med­ical Oncol­o­gist Con­sul­tant, Flinders Med­ical Centre

Mr Arrin Wislang

Man­ag­er (Clin­i­cal Ser­vices), Rur­al Sup­port Service

Dr Ben­jamin Saxon

Med­ical Unit Head (Haema­tol­ogy and Oncol­o­gy), WCHN

Ms Car­ol MooreSenior Man­ag­er Accom­mo­da­tion Ser­vices, Can­cer Coun­cil SA
Prof Cather­ine PatersonPro­fes­sor of Can­cer Nurs­ing, Car­ing Futures Insti­tute, Flinders Uni­ver­si­ty; Co-Lead Can­cer Sur­vivor­ship Research Pro­gram, CALHN

Ms Cheri Ostroff

Con­sumer representative 

Prof David Roder

Research Chair (Can­cer Epi­demi­ol­o­gy and Pop­u­la­tion Health), UniSA; Senior Prin­ci­pal Research Fel­low, SAHMRI

Dr Eliz­a­beth Murphy

Divi­sion­al Direc­tor (Med­ical) Divi­sion of Sur­gi­cal Spe­cial­ties and Anaes­thet­ics; Col­orec­tal Sur­geon, NALHN

Ms Ellen Mills

State Man­ag­er (SA), Inter­im State Man­ag­er (WA), Icon Can­cer Centre
Ms Erin ShooterCan­cer Nurse Edu­ca­tor, CALHN

Ms Gabrielle Vigar

Clin­i­cal Lec­tur­er, Ade­laide Nurs­ing School, Uni­ver­si­ty of Ade­laide; Nurse Unit Man­ag­er, (Radi­a­tion Oncology/​Can­cer Out­pa­tients), RAH

Ms Hay­ley Vasileff

Lead Can­cer Ser­vices Phar­ma­cist, SA Pharmacy/​Rur­al Sup­port Service

Mrs Helen Phillips

Advanced Nurse Con­sul­tant, (Can­cer Ser­vices Team), Rur­al Sup­port Service

Dr Hui-Peng LeeHaema­tol­o­gist, SALHN
Dr Jakub JagielloOrthopaedic Oncol­o­gy Con­sul­tant, SALHN

Ms Joanne Glover

Inter­im Exec­u­tive Direc­tor, Bragg Com­pre­hen­sive Can­cer Cen­tre; Affil­i­ate Senior Lec­tur­er Ade­laide Med­ical School, Uni­ver­si­ty of Adelaide

Dr Jus­tine ClarkPost­doc­tor­al Research Fel­low (Indige­nous Genomics), Telethon Kids Institute

Ms Kim Morey 

Co-Theme Leader (Abo­rig­i­nal Health Equi­ty Strat­e­gy Health Sys­tems Research), SAHMRI

Ms Kim­ber­ley-Ann KerrPhar­ma­cy Ana­lyst (ECPS Project), Dig­i­tal Health SA
Mr Luke PeetersAphere­sis Nurse Con­sul­tant (Haema­tol­ogy Depart­ment), Flinders Med­ical Centre
Prof Lyle PalmerPro­fes­sor of Genet­ic Epi­demi­ol­o­gy, Uni­ver­si­ty of Adelaide
Dr Mar­cus DreostiRadi­a­tion Oncol­o­gist; Med­ical Direc­tor Radi­a­tion Oncol­o­gy (Aus­tralia); Med­ical Direc­tor Oncol­o­gy (SA), GenesisCare

Mr Mark Haseloff

Con­sumer representative 

Dr Mark McGregorCon­sul­tant Med­ical Oncol­o­gist, Lyell McEwin Hospital

Mr Michael Fitzgerald

Nurse Prac­ti­tion­er, Med­ical Oncol­o­gy (Can­cer Ser­vices); Flinders Med­ical Centre

Dr Peter Bardy

Haema­tol­o­gist Con­sul­tant, CALHN

Mr Rohan Miegel

Phys­io­ther­a­pist, SALHN

Mrs Shan­delle Hill

Out­pa­tient Nurse Con­sul­tant, Michael Rice Cen­tre for Haematology/​Oncol­o­gy, WCHN

Prof Tim­o­thy Price

Med­ical Oncol­o­gist, TQEH; Med­ical Lead Can­cer Pro­gram, CALHN

Ms Vic­ki HumePro­gram Direc­tor (Can­cer Pro­gram), CALHN

Dr Michael Osborn

Cancer SCN Clinical Lead

Con­sul­tant Oncologist/​Haema­tol­o­gist

Dr Michael Osborn works at the Women’s and Children’s Hos­pi­tal and has also led the South Aus­tralian Youth Can­cer Ser­vice at the Roy­al Ade­laide Hos­pi­tal since its incep­tion in 2011. His main clin­i­cal and research inter­ests are leukaemia in chil­dren, ado­les­cents and young adults (AYA), as well as exer­cise in can­cer, and improv­ing health­care deliv­ery for chil­dren and AYA with can­cer. He was active­ly involved in the devel­op­ment and imple­men­ta­tion of Youth Can­cer Ser­vices in Aus­tralia at a nation­al and state lev­el. He is cur­rent­ly the Aus­tralian prin­ci­pal inves­ti­ga­tor for a relapsed acute lym­phoblas­tic leukaemia clin­i­cal tri­al, as well as being involved in a num­ber of oth­er clin­i­cal research stud­ies. Michael is com­mit­ted to work­ing col­lab­o­ra­tive­ly to improve the expe­ri­ence and out­comes for all South Aus­tralians with cancer. 

Can­cer Statewide Clin­i­cal Net­work Vision

The Can­cer Clin­i­cal Net­work’s vision is for excel­lence and inno­va­tion in can­cer care for South Australians.

Can­cer Statewide Clin­i­cal Net­work Goals

The Can­cer Statewide Clin­i­cal Net­work aims to bring togeth­er health pro­fes­sion­als and con­sumers to pro­vide strate­gic guid­ance and advice relat­ing to can­cer care and work on projects to improve health out­comes for all South Aus­tralians affect­ed by cancer.

The Can­cer Statewide Clin­i­cal Net­work aims to improve health out­comes for all South Aus­tralians affect­ed by can­cer. We do this by:

  • being per­­son-cen­tred.
  • focus­ing on com­pas­sion­ate and equi­table care.
  • work­ing in col­lab­o­ra­tive part­ner­ships with key stake­hold­ers across the entire can­cer continuum.
  • build­ing on lat­est evi­dence to dri­ve excel­lence and innovation.
  • dri­ving improve­ments in safe­ty, qual­i­ty and patient experience.
  • pro­vid­ing strate­gic exper­tise and advice on can­cer care.

Achieve­ments of the Can­cer Statewide Clin­i­cal Network

  • Sys­temic ther­a­py stan­dards – state-wide vs nation­al mapping
  • Devel­op­ment of data strat­e­gy for can­cer outcomes
  • Com­ple­tion of a​‘stan­dard sys­temic can­cer treat­ment’ con­sent form
  • Com­menced Chemother­a­py Nation­al Stan­dards Sup­port­ing document
  • Devel­op­ment of COVID-19 can­cer vac­ci­na­tion doc­u­ments – for con­sumers and health professionals

Addi­tion­al Doc­u­ments and Information

Terms of Reference

Have a question?

Or want to know more about the Can­cer Statewide Clin­i­cal Net­work?
Please email CEIHCancer@​sa.​gov.​au